- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 47/48 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
Patent holdings for IPC class A61K 47/48
Total number of patents in this class: 9219
10-year publication summary
|
1808
|
1805
|
500
|
118
|
57
|
44
|
34
|
13
|
1
|
0
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Nektar Therapeutics | 503 |
171 |
| The Regents of the University of California | 18943 |
122 |
| Genentech, Inc. | 3742 |
94 |
| Massachusetts Institute of Technology | 9795 |
82 |
| F. Hoffmann-La Roche AG | 7958 |
75 |
| Novo Nordisk A/S | 2324 |
72 |
| ImmunoGen, Inc. | 405 |
68 |
| The Johns Hopkins University | 5377 |
64 |
| Novartis AG | 11238 |
60 |
| Centre National de La Recherche Scientifique | 9632 |
55 |
| Allergan, Inc. | 2600 |
53 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2737 |
53 |
| MedImmune Limited | 627 |
51 |
| Bristol-myers Squibb Company | 5080 |
48 |
| Immunomedics, Inc. | 290 |
47 |
| Board of Regents, The University of Texas System | 5370 |
45 |
| Pfizer Inc. | 3322 |
42 |
| Ascendis Pharma A/S | 173 |
40 |
| SeaGen Inc | 554 |
38 |
| Alnylam Pharmaceuticals, Inc. | 1066 |
37 |
| Other owners | 7902 |